Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Phase II trials begin on ICOS MS treatment

Jan. 20, 1997

Conclusion of Cephalon/Schering-Plough AD collaboration

Jan. 17, 1997

Novel antioxidant disclosed by Nippon Chemiphar

Jan. 17, 1997

Japanese investigators isolate novel aminopeptidase inhibitor

Jan. 17, 1997

New dopamine receptor ligands reported by Roche

Jan. 17, 1997

Avonex update presented

Jan. 16, 1997

Fujisawa characterizes novel antidementia agent

Jan. 16, 1997

Neuroprotective agent described by Taisho

Jan. 16, 1997

Ortho reports analgesic drug candidates

Jan. 16, 1997

Johns Hopkins investigators report new growth factor

Jan. 16, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...